Salarius Pharmaceuticals (NASDAQ:SLRX) Cut to “Sell” at Wall Street Zen
Wall Street Zen cut shares of Salarius Pharmaceuticals (NASDAQ:SLRX – Free Report) from a hold rating to a sell rating in a report published on Saturday morning. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Salarius Pharmaceuticals in a research note on Monday, December 29th. One investment analyst has rated the stock […]
6 Jan 01:32 · The Cerbat Gem